

MULTICENTRIC PARAGANGLIOMA - A RARE CASE PRESENTATION
Abstract
Keywords
References
Carney JA, Sheps SG, Go VL, and Gordon H. (1977). “The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma”,N Engl J Med,Vol.296, pp.1517-1518.
Eisenhofer G, Bornstein SR, Brouwers FM, Cheung NK, Dahia PL, de Krijger RR, Giordano TJ, Greene LA, Goldstein DS, Lehnert H, Manger WM, Maris JM, Neumann HP, Pacak K, Shulkin BL, Smith DI, Tischler AS, and Young WF Jr.(2004). “Malignant pheochromocytoma: current status and initiatives for future progress”, EndocrRelat Cancer, Vol.11(3), pp.423-436.
Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA, and Young WF Jr. (2001). “Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients”, Journal of Clinical Endocrinology and Metabolism, Vol.86(11), pp.5210-5216.
Gimenez-Roqueplo AP. (2006). “New advances in the genetics of pheochromocytoma and paraganglioma syndromes”,Ann N Y Acad Sci.,Vol.1073, pp.112-121.
Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Crespin M, Nau V, Khau Van Kien P, Corvol P, Plouin PF, Jeunemaitre X. and COMETE Network. (2003). “Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas”,Cancer Res, Vol.63(17), pp.5615-5621.
Grufferman S, Gillman MW, Pasternak LR, Peterson CL, and Young WG Jr. (1980). “Familial carotid body tumors: case report and epidemiologic review”, Cancer,Vol.46, pp.2116-2122.
Lee JH, Barich F, Karnell LH, Robinson RA, Zhen WK, Gantz BJ, and Hoffman HT, American College of Surgeons Commission on Cancer, and American Cancer Society. (2002). “National Cancer Data Base report on malignant paragangliomas of the head and neck”,Cancer,Vol.94(3), pp.730-737.
Magliulo G, Zardo F, Varacalli S, and D'Amico R. (2003). “Multiple paragangliomas of the head and neck”,An OtorrinolaringolIbero Am,Vol.30, pp.31 -38.
Mangner TJ, Tobes MC, Wieland DW, Sisson JC, and Shapiro B. (1986). “Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma”,J Nucl Med,Vol.27, pp.37-44.
Nomura K, Kimura H, Shimizu S, Kodama H, Okamoto T, Obara T, and Takano K. (2009). “Survival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine, and dacarbazine chemotherapy”,J ClinEndocrinolMetab, Vol.94(8), pp.2850-2856.
Olsen WL, Dillon WP, Kelly WM, Norman D, Brant-Zawadzki M, and Newton TH. (1987). “MR imaging of paragangliomas”,AJR, Vol.148, pp.201 -204.
Quint LE, Glazer GM, Francis IR, Shapiro B, and Chenevert TL. (1987). “Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy”,Radiology,Vol.165, pp.89-93.
Shapiro B, Sisson JC, Shulkin BL, Gross MD, and Zempel S. (1995). “The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuroendocrine tumors”, Q J Nucl Med, Vol.39 (suppl 1), pp.3-8.
van Gils AP, Falke TH, van Erkel AR, Arndt JW, Sandler MP, van der Mey AG, and Hoogma RP. (1991). “MR imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas”,Radio Graphics,Vol.11, pp.37-57.
Young AL, BaysalBE, Deb A, and Young WF Jr. (2002). “Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene, J Clin Endocrinol Metab,Vol.87, pp.4101-4105.
Refbacks
- There are currently no refbacks.
Send mail to ijsss@ijsss.com with questions or comments about this web site.
International Journal of Surgery and Surgical Sciences, All rights reserved.